Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
The biomarker can identify beta cell death in children and adults with recent-onset Type 1 diabetes and in antibody-positive at-risk subjects before disease onset.
Beta cells in the pancreas produce the body’s insulin, and their loss or dysfunction causes diabetes.
This discovery may help treat patients with refractory thrombotic thrombocytopenic microangiopathy.
Researchers will study chemical modifications on RNA in postmortem brains.
The radioactivity of scandium 43 dwindles fast, with a half-life of just 3.9 hours.
This regenerative potential is lost within days after birth, which is why adult heart attacks lead to heart failure.
This method — tested in a mouse heart attack model — doubled the engraftment rate of injected stem cell-derived cardiomyocytes.
Researchers mapped distinct bone marrow niche populations and their differentiation paths.
This is a potential mechanistic underpinning — at least in a subset of patients — for the altered behaviors observed in autism.
“Attending the World Congress on Undergraduate Research … was the highlight of my college career.” – Saakshi Thukral